BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Christian D. Fingas, Joachim C. Mertens, Nataliya Razumilava, Steven F. Bronk, Alphonse E. Sirica, Gregory J. Gores. Targeting PDGFR-β in CholangiocarcinomaLiver International 2011; : n/a doi: 10.1111/j.1478-3231.2011.02687.x
2
Wen-Ling Kuo, Ming-Chin Yu, Ju-Fang Lee, Chi-Neu Tsai, Tse-Ching Chen, Miin-Fu Chen. Imatinib Mesylate Improves Liver Regeneration and Attenuates Liver Fibrogenesis in CCL4-Treated MiceJournal of Gastrointestinal Surgery 2012; 16(2): 361 doi: 10.1007/s11605-011-1764-7
3
Marcus Wiedmann, J??rgen Feisthammel, Thilo Bl??thner, Andrea Tannapfel, Thomas Kamenz, Annett Kluge, Joachim M??ssner, Karel Caca. Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinibAnti-Cancer Drugs 2006; 17(7): 783 doi: 10.1097/01.cad.0000217433.48870.37
4
Luca Fabris, Massimiliano Cadamuro, Lidia Moserle, James Dziura, Xiangyu Cong, Luisa Sambado, Giorgia Nardo, Aurelio Sonzogni, Michele Colledan, Alberto Furlanetto, Nicolò Bassi, Marco Massani, Umberto Cillo, Claudia Mescoli, Stefano Indraccolo, Massimo Rugge, Lajos Okolicsanyi, Mario Strazzabosco. Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasizationHepatology 2011; 54(3): 890 doi: 10.1002/hep.24466
5
Jan-Hendrik Egberts, Bodo Schniewind, Clemens Schafmayer, Marie-Luise Kruse, Bence Sipos, Fred Fändrich, Holger Kalthoff, Jürgen Tepel. Establishment of a novel orthotopic xenograft model of human gallbladder carcinomaClinical & Experimental Metastasis 2007; 24(3): 141 doi: 10.1007/s10585-007-9058-x
6
J??rgen Feisthammel, Konrad Schoppmeyer, Joachim M??ssner, Manfred Schulze, Karel Caca, Marcus Wiedmann. Irinotecan With 5-FU/FA in Advanced Biliary Tract AdenocarcinomasAmerican Journal of Clinical Oncology 2007; 30(3): 319 doi: 10.1097/01.coc.0000258124.72884.7a
7
Marcus Wiedmann, Helmut Witzigmann, Joachim Mössner. Clinical Hepatology2010; : 1519 doi: 10.1007/978-3-642-04519-6_62
8
Florian Eckel, Roland M Schmid. Emerging drugs for biliary cancerExpert Opinion on Emerging Drugs 2007; 12(4): 571 doi: 10.1517/14728214.12.4.571
9
Federico Moriconi, Pierluigi Ramadori, Frank C. Schultze, Martina Blaschke, Ahmad Amanzada, Sajjad Khan, Giuliano Ramadori. Characterization of the erythropoietin/erythropoietin receptor axis in a rat model of liver damage and cholangiocarcinoma developmentHistochemistry and Cell Biology 2013; 139(3): 473 doi: 10.1007/s00418-012-1037-x